New Jersey ACR 138: Urges FDA to expedite approval of additional epinephrine auto-injector device products.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2018-02-08)

State: New Jersey · Session: 218 · Bill: ACR 138

Subjects: PHARMACEUTIC

Sponsors: Conaway, Herb

View New Jersey ACR 138 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.